Honest Company (NASDAQ: HNST) disclosed an insider transaction by Chief Innovation Officer Stephen Winchell in a Form 4 filed with the Securities and Exchange Commission. The filing shows Winchell sold 73,685 shares of common stock on March 3, 2026.
The shares moved at a weighted average price of $2.84. Reported execution prices for individual lots ranged from $2.83 to $2.87, and the total proceeds from the sale were $209,265. Following the disposition, Winchell directly owns 517,466 shares of the company, a total that includes 444,422 restricted stock units.
Market action since the filing has seen Honest Company shares reach $2.93, a level that represents a roughly 5% increase over the trailing week. Third-party analysis from InvestingPro cited in company commentary indicates that HNST appears undervalued at present, with the platform’s Fair Value assessment pointing to upside potential. The InvestingPro profile also assigns the company a "GOOD" financial health score while cautioning that the stock demonstrates high volatility. Additional research materials, including a Pro Research Report, are available for HNST and more than 1,400 U.S. equities through that service.
Separately, the company released its fourth-quarter 2025 financial results. Honest Company reported an earnings per share loss of $0.21 for the quarter, a figure that fell short of the consensus expectation of a $0.01 profit. On the top line, revenue for the period came in at $88.04 million, modestly above the anticipated $87.7 million.
On the institutional research front, Morgan Stanley left its rating on Honest Company unchanged at Equalweight and set a $3.00 price target. The firm noted that the company’s fourth-quarter results and the initial fiscal 2026 guidance were above market expectations, observations Morgan Stanley said are reflected in its view of the company’s valuation.
The combination of an insider sale, mixed quarterly results and divergent third-party evaluations contributes to a complex picture for investors. The filing provides a clear record of the trade and the company disclosures offer data points on recent financial performance and analyst positioning. Market participants looking to assess HNST should weigh the reported stock sale, the quarterly operational metrics, and the publicly stated analyst views alongside the stock’s noted volatility.